|Bid||93.97 x 1000|
|Ask||94.00 x 900|
|Day's Range||92.53 - 95.83|
|52 Week Range||31.60 - 96.54|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||52.00|
|Earnings Date||May 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||114.00|
Biotech stock Horizon Therapeutics is set up below a buy point, ahead of earnings, after soaring 102% in 2020. Can it do it again?
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has been named one of Fortune’s 100 Best Companies to Work For® in the United States. This is Horizon’s first time being included on the list.
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its first-quarter 2021 financial results will be released on Wednesday, May 5, 2021. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.